The pharmaceutical sector shows a healthy growth. Bankruptcies is this sector are mainly those of pharmaceutical traders or distributors.

Nobili advises pharmaceutical companies relating to:

  • bankruptcy of partner companies (pharmaceutical traders, distributors and others), which influence the activities and sustainability of pharmaceutical companies
  • dispute resolution
  • assessment of bankruptcy risks of pharmaceutical companies, pharmaceutical traders and others market players
  • debtor-initiated bankruptcy proceedings
  • representing the creditors in bankruptcy proceedings of pharmaceutical companies
  • representing pharmaceutical companies in bankruptcy proceedings
  • representation in criminal proceedings on the alleged bankruptcy fraud
  • counteractions to fictitious bankruptcies


Client: a pharmacy network

Nobili represented the client on challenging the notices and decisions of the tax authorities in courts.  The dispute was resolved by the ruling of the Supreme Administrative Court, which invalidated the notices and decisions of the tax authorities in favor of the client.

Deal Value: about USD 480 000